Richard Nolan Townsend - 16 May 2025 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Chief Executive Officer, Director
Signature
/s/ Youjin Choi, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
16 May 2025
Net transactions value
-$2,979
Form type
4
Filing time
20 May 2025, 17:00:15 UTC
Previous filing
01 Apr 2025
Next filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Townsend Richard Nolan Chief Executive Officer, Director C/O LEXEO THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK /s/ Youjin Choi, Attorney-in-Fact 20 May 2025 0001995218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXEO Common Stock Sale $2,979 -1,074 -0.48% $2.77 221,173 16 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
F2 Includes 133,827 RSUs.